These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1670946)

  • 1. IL-1 alpha is produced by T lymphocytes activated via the CD2 plus CD28 pathways.
    Cerdan C; Martin Y; Brailly H; Courcoul M; Flavetta S; Costello R; Mawas C; Birg F; Olive D
    J Immunol; 1991 Jan; 146(2):560-4. PubMed ID: 1670946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation.
    Cerdan C; Martin Y; Courcoul M; Brailly H; Mawas C; Birg F; Olive D
    J Immunol; 1992 Oct; 149(7):2255-61. PubMed ID: 1356123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells.
    Costello R; Cerdan C; Pavon C; Brailly H; Hurpin C; Mawas C; Olive D
    Eur J Immunol; 1993 Mar; 23(3):608-13. PubMed ID: 8095456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of the CD2 and CD28 T lymphocyte activation pathways to the regulation of the expression of the colony-stimulating factor (CSF-1) gene.
    Cerdan C; Razanajaona D; Martin Y; Courcoul M; Pavon C; Mawas C; Olive D; Birg F
    J Immunol; 1992 Jul; 149(2):373-9. PubMed ID: 1352526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "CD3low" human thymocyte populations can readily be triggered via the CD2 and/or CD28 activation pathways whereas the CD3 pathway remains nonfunctional.
    Pierres A; Cerdan C; Lopez M; Mawas C; Olive D
    J Immunol; 1990 Feb; 144(4):1202-7. PubMed ID: 1968076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of primary human T-lymphocytes through CD2 plus CD28 adhesion molecules induces long-term nuclear expression of NF-kappa B.
    Costello R; Lipcey C; Algarté M; Cerdan C; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Apr; 4(4):329-39. PubMed ID: 8098618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28-stimulated IL-2 gene expression in Jurkat T cells occurs in part transcriptionally and is cyclosporine-A sensitive.
    Williams TM; Moolten DM; Makni H; Kim HW; Kant JA; Kamoun M
    J Immunol; 1992 Apr; 148(8):2609-16. PubMed ID: 1348520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
    Damle NK; Doyle LV
    J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-7 is a potent co-stimulus of the adhesion pathway involving CD2 and CD28 molecules.
    Costello R; Brailly H; Mallet F; Mawas C; Olive D
    Immunology; 1993 Nov; 80(3):451-7. PubMed ID: 7904590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CD2 cross-linking in cytoplasmic calcium responses and T cell activation.
    Ledbetter JA; Rabinovitch PS; Hellström I; Hellström KE; Grosmaire LS; June CH
    Eur J Immunol; 1988 Oct; 18(10):1601-8. PubMed ID: 2461308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of NF-kappa B1 (p50/p105) gene expression in activation of human blood T-lymphocytes via CD2 and CD28 adhesion molecules.
    Costello R; Cerdan C; Lipcey C; Algarté M; Martin Y; Baeuerle PA; Olive D; Imbert J
    Cell Growth Differ; 1993 Nov; 4(11):947-54. PubMed ID: 7905283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 induces tumor necrosis factor-alpha production by activated human T cells via a cyclosporin-sensitive pathway.
    Lorré K; Fransen L; Ceuppens JL
    Eur Cytokine Netw; 1992; 3(3):321-30. PubMed ID: 1353987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T cell responses to IL-1 and IL-6 are dependent on signals mediated through CD2.
    Endler-Jobst B; Schraven B; Hutmacher B; Meuer SC
    J Immunol; 1991 Mar; 146(6):1736-42. PubMed ID: 1706379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T; Allison JP; Davidson WF
    J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
    Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
    J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
    J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of T-cell differentiation by CD2 and CD28 accessory molecules.
    de Jong R; Stokkers P; Lamme E; Kool JM; Borst F; Brouwer M; Miedema F; van Lier RA
    Immunology; 1991 Oct; 74(2):175-82. PubMed ID: 1684171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules.
    Massaia M; Perrin L; Bianchi A; Ruedi J; Attisano C; Altieri D; Rijkers GT; Thompson LF
    J Immunol; 1990 Sep; 145(6):1664-74. PubMed ID: 1975259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways.
    Butler JJ; Mader JS; Watson CL; Zhang H; Blay J; Hoskin DW
    J Cell Biochem; 2003 Aug; 89(5):975-91. PubMed ID: 12874832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bidirectional regulatory network involving IL 2 and IL 4 in the alternative CD2 pathway of T cell activation.
    Lorré K; Van Damme J; Ceuppens JL
    Eur J Immunol; 1990 Jul; 20(7):1569-75. PubMed ID: 1974850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.